MWNA
ARA

Marshall Wace North America’s American Renal Associates Holdings, Inc ARA Stock Holding History

Marshall Wace North America’s Portfolio ARA Stock Details ARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-15,277
Closed -$266K – 1811
2017
Q4 		$266K Buy
+15,277
New +$211K ﹤0.01% 1248

Other funds holding ARA

CP
Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WIC
Whitegate Investment Counselors Concord, New Hampshire $315M AUM 10.6% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return

Marshall Wace North America's ARA Position: Q1 2018 in Review

Marshall Wace North America sold out of American Renal Associates Holdings, Inc (ARA) in Q1 2018, closing a stake of 15,277 shares — an estimated $266K sold.

Marshall Wace North America first reported a position in ARA in Q4 2017 and held it in 1 quarter. The position peaked at $266K in Q4 2017. 82 funds tracked by Wall St. Rank hold ARA as of Q1 2018.

  • Marshall Wace North America reported no remaining American Renal Associates Holdings, Inc position as of Q1 2018 after selling out during the quarter.
  • Marshall Wace North America sold 15,277 American Renal Associates Holdings, Inc shares in Q1 2018, an estimated $266K.
  • Marshall Wace North America first reported a position in American Renal Associates Holdings, Inc in Q4 2017 and held it in 1 quarter.
  • Marshall Wace North America's American Renal Associates Holdings, Inc position peaked at $266K in Q4 2017.
  • 82 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q1 2018.

Based on Marshall Wace North America's 13F filing for Q1 2018, filed 15 May 2018.